Article ; Online: Comparison of 2 Immunosuppression Minimization Strategies in Kidney Transplantation: The ALLEGRO Trial.
2024 Volume 108, Issue 2, Page(s) 556–566
Abstract: Background: Evidence on the optimal maintenance of immunosuppressive regimen in kidney transplantation recipients is limited.: Methods: The Amsterdam, LEiden, GROningen trial is a randomized, multicenter, investigator-driven, noninferiority, open- ... ...
Abstract | Background: Evidence on the optimal maintenance of immunosuppressive regimen in kidney transplantation recipients is limited. Methods: The Amsterdam, LEiden, GROningen trial is a randomized, multicenter, investigator-driven, noninferiority, open-label trial in de novo kidney transplant recipients, in which 2 immunosuppression minimization strategies were compared with standard immunosuppression with basiliximab, corticosteroids, tacrolimus, and mycophenolic acid. In the minimization groups, either steroids were withdrawn from day 3, or tacrolimus exposure was reduced from 6 mo after transplantation. The primary endpoint was kidney transplant function at 24 mo. Results: A total of 295 participants were included in the intention-to-treat analysis. Noninferiority was shown for the primary endpoint; estimated glomerular filtration rate at 24 mo was 45.3 mL/min/1.73 m 2 in the early steroid withdrawal group, 49.0 mL/min/1.73 m 2 in the standard immunosuppression group, and 44.7 mL/min/1.73 m 2 in the tacrolimus minimization group. Participants in the early steroid withdrawal group were significantly more often treated for rejection ( P = 0.04). However, in this group, the number of participants with diabetes mellitus during follow-up and total cholesterol at 24 mo were significantly lower. Conclusions: Tacrolimus minimization can be considered in kidney transplant recipients who do not have an increased immunological risk. Before withdrawing steroids the risk of rejection should be weighed against the potential metabolic advantages. |
---|---|
MeSH term(s) | Humans ; Tacrolimus/adverse effects ; Kidney Transplantation/adverse effects ; Immunosuppressive Agents/adverse effects ; Immunosuppression Therapy ; Mycophenolic Acid/adverse effects ; Steroids ; Graft Rejection/prevention & control ; Carbazoles ; Tryptamines |
Chemical Substances | Tacrolimus (WM0HAQ4WNM) ; frovatriptan (H82Q2D5WA7) ; Immunosuppressive Agents ; Mycophenolic Acid (HU9DX48N0T) ; Steroids ; Carbazoles ; Tryptamines |
Language | English |
Publishing date | 2024-01-19 |
Publishing country | United States |
Document type | Randomized Controlled Trial ; Multicenter Study ; Journal Article |
ZDB-ID | 208424-7 |
ISSN | 1534-6080 ; 0041-1337 |
ISSN (online) | 1534-6080 |
ISSN | 0041-1337 |
DOI | 10.1097/TP.0000000000004776 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 488: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 509: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.